BRADLY KELLER: Open Payments
NPI 1265462378 · MCKINNEY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$271 in 11 payments from 7 companies in 2025. Trend: 2023 $101 · 2024 $77 · 2025 $271
Food & beverage: $271
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $66 |
| Teva Pharmaceuticals USA, Inc. | 2 | $58 |
| E.R. Squibb & Sons, L.L.C. | 2 | $45 |
| Janssen Pharmaceuticals, Inc | 2 | $32 |
| Luye Pharma (USA) Ltd. | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Tris Pharma Inc | 1 | $19 |
Products named: INGREZZA, UZEDY, COBENFY, INVEGA SUSTENNA, ERZOFRI EXTENDED-RELEASE, ABILIFY MAINTENA, Dyanavel XR.
Industry payments across TX — which companies pay providers there.
